Comparing new cancer treatments for dogs
COMPARATIVE ONCOLOGY CLINICAL TRIALS
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-10281308
This study is testing new cancer treatments for dogs to find out which ones work best, so we can help our furry friends who are battling cancer feel better and live longer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10281308 on ClinicalTrials.gov |
What this research studies
This research focuses on conducting clinical trials to evaluate the effectiveness of new anti-cancer agents specifically for dogs. By comparing various experimental therapies, the study aims to identify the most promising treatments that could improve outcomes for canine patients with cancer. The trials will involve enrolling dogs diagnosed with neoplastic diseases to assess how well these new treatments work compared to existing options. The approach is designed to gather data that can lead to better therapeutic strategies for dogs suffering from cancer.
Who could benefit from this research
Good fit: Ideal candidates for participation are dogs diagnosed with cancer who are eligible for experimental treatment options.
Not a fit: Dogs with non-cancerous conditions or those not eligible for clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments for dogs, improving their quality of life and survival rates.
How similar studies have performed: Previous comparative oncology trials have shown promise in identifying effective treatments for canine cancer, indicating that this approach has potential for success.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PARCHMENT, RALPH — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: PARCHMENT, RALPH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents, Cancer Drug, Neoplastic Disease Chemotherapeutic Agents, anti-cancer drug, anticancer agent